|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 233/18 | |
| C07C 233/47 | |||
| A61K 31/165 | |||
| A61K 31/195 | |||
| A61P 25/00 | |||
| A61P 25/18 | |||
| A61P 25/20 | |||
| A61P 25/22 | |||
| A61P 25/24 | |||
| A61P 25/28 |
| (11) | Patento numeris | 2855424 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13724708.6 |
| Europos patento paraiškos padavimo data | 2013-05-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/041573 |
| Data | 2013-05-17 |
| (87) | Numeris | WO 2013/173707 |
| Data | 2013-11-21 |
| (30) | Numeris | Data | Šalis |
| 201261649220 P | 2012-05-18 | US |
| (72) |
DRESSMAN, Marlene, Michelle, US
PHADKE, Deepak, US
|
| (73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Avenue NW Suite 300, Washington, DC 20037,
US
|
| (54) | METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPROPYL]METHYL]PROPANAMIDE |
| METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPROPYL]METHYL]PROPANAMIDE |